Brief: Catalyst Pharmaceuticals Enters Into Agreement With Kye Pharmaceuticals For Agamree® In Canada

Catalyst Pharmaceuticals

24/07/2024 13:52

July 24 (Reuters) - Catalyst Pharmaceuticals Inc
 CPRX.O :
    * CATALYST PHARMACEUTICALS ENTERS INTO AN EXCLUSIVE LICENSE,
SUPPLY AND COMMERCIALIZATION AGREEMENT WITH KYE PHARMACEUTICALS
FOR AGAMREE® IN CANADA

Source text for Eikon:  ID:nGNX9340hD 
Further company coverage:  CPRX.O 

 ((Reuters.Briefs@thomsonreuters.com;))